Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Acetabularia (Phase 3)
Amyotrophic Lateral Sclerosis (Phase 1/Phase 2)
Anemia, Sickle Cell (Phase 1)
Angina Pectoris (Phase 2)
Autism Spectrum Disorder (Phase 2)
Back Pain (Phase 2)
Behcet Syndrome (Phase 1)
Biliary Atresia (Phase 1)
Bone Marrow Cells (Phase 2)
Brain Injuries, Traumatic (Phase 2)
Cartilage, Articular (Phase 3)
Cartilage Diseases (Phase 1/Phase 2)
Cerebral Palsy (Phase 2)
Chronic Limb-Threatening Ischemia (Phase 1)
Colitis, Ulcerative (Phase 1)
Colonic Pouches (Phase 1)
Crohn Disease (Phase 2)
Diabetes Mellitus, Type 1 (Phase 1)
Diabetes Mellitus, Type 2 (Phase 2)
Diabetic Foot (Phase 1)
Femoracetabular Impingement (Phase 3)
Fistula (Phase 1)
Fractures, Bone (Phase 1/Phase 2)
Frailty (Phase 1/Phase 2)
Gangrene (Phase 1)
Heart Diseases (Phase 1/Phase 2)
Ileum (Phase 1)
Inflammatory Bowel Diseases (Phase 1)
Intervertebral Disc Degeneration (Phase 2)
Ischemia (Phase 1)
Joint Diseases (Phase 1/Phase 2)
Knee Injuries (Phase 1/Phase 2)
Leg Ulcer (Phase 1)
Leukemia (Phase 1)
Leukemia, Myeloid, Acute (Phase 3)
Liver Cirrhosis (Phase 3)
Liver Cirrhosis, Alcoholic (Phase 1)
Liver Cirrhosis, Biliary (Phase 2)
Liver Transplantation (Phase 2/Phase 3)
Macular Degeneration (Phase 1)
Mesenchymal Stem Cells (Phase 4)
Multiple Sclerosis (Phase 2)
Multiple System Atrophy (Phase 1)
Myelodysplastic Syndromes (Phase 3)
Myocardial Infarction (Phase 2/Phase 3)
Myocardial Ischemia (Phase 2)
Osteoarthritis (Phase 3)
Osteoarthritis, Knee (Phase 3)
Ovarian Diseases (Phase 3)
Peripheral Vascular Diseases (Phase 1)
Pouchitis (Phase 1)
Primary Ovarian Insufficiency (Phase 1)
Pseudarthrosis (Phase 1/Phase 2)
Rectal Fistula (Phase 1)
Respiratory Distress Syndrome (Phase 2)
Retinal Degeneration (Phase 1)
Retinitis (Phase 1)
Retinitis Pigmentosa (Phase 1)
Rheumatic Diseases (Phase 1/Phase 2)
Spinal Cord Injuries (Phase 1/Phase 2)
Stargardt Disease (Phase 1)
Waldenstrom Macroglobulinemia (Phase 4)
Xerostomia (Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue